Junichi Sakamoto Selected Research

Tegafur

2/2022	Prospective observational study of the efficacy of oral uracil and tegafur plus leucovorin for stage II colon cancer with risk factors for recurrence using propensity score matching (JFMC46-1201).
11/2019	Impact of pathological stage and histological subtype on clinical outcome of adjuvant chemotherapy of paclitaxel plus carboplatin versus oral uracil-tegafur for non-small cell lung cancer: subanalysis of SLCG0401 trial.
9/2018	A randomized phase III study of hepatic arterial infusion chemotherapy with 5-fluorouracil and subsequent systemic chemotherapy versus systemic chemotherapy alone for colorectal cancer patients with curatively resected liver metastases (Japanese Foundation for Multidisciplinary Treatment of Cancer 32).
1/2018	A Multicenter Randomized Controlled Study of Paclitaxel plus Carboplatin versus Oral Uracil-Tegafur as the Adjuvant Chemotherapy in Resected Non-Small Cell Lung Cancer.
1/2018	Randomized phase III trial comparing surgery alone to UFT + PSK for stage II rectal cancer (JFMC38 trial).
1/2015	[A case of recurrent gastric cancer successfully treated with S-1 oral administration].
7/2014	Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial.
4/2010	A comparison of multimodality treatment: two or four courses of paclitaxel plus cisplatin or S-1 plus cisplatin followed by surgery for locally advanced gastric cancer, a randomized Phase II trial (COMPASS).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Junichi Sakamoto Research Topics

Disease

84	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2002
61	Colorectal Neoplasms (Colorectal Cancer) 12/2022 - 09/2003
49	Neoplasms (Cancer) 06/2022 - 09/2003
17	Colonic Neoplasms (Colon Cancer) 10/2022 - 10/2004
17	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2020 - 12/2012
13	Neoplasm Metastasis (Metastasis) 02/2021 - 08/2006
12	Diarrhea 05/2018 - 01/2004
11	Neutropenia 12/2020 - 01/2004
11	Breast Neoplasms (Breast Cancer) 09/2014 - 02/2004
10	Carcinoma (Carcinomatosis) 02/2022 - 05/2003
10	Ascites 01/2020 - 05/2003
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2021 - 05/2001
6	Disease Progression 01/2018 - 07/2007
5	Body Weight (Weight, Body) 10/2018 - 11/2004
5	Adenocarcinoma 01/2018 - 07/2007
5	Fatigue 01/2018 - 01/2004
5	Stomatitis 01/2018 - 01/2004
4	Lymphatic Metastasis 10/2020 - 07/2009
4	Anemia 01/2018 - 11/2008
4	Hypersensitivity (Allergy) 09/2016 - 03/2013
4	Leukopenia 08/2012 - 01/2004
3	Rectal Neoplasms (Rectal Cancer) 01/2022 - 01/2018
3	Pain (Aches) 10/2021 - 06/2009
3	Lung Neoplasms (Lung Cancer) 05/2021 - 04/2017
3	Wilms Tumor (Wilm's Tumor) 02/2019 - 05/2008
3	Anorexia 01/2018 - 01/2004
3	Obesity 01/2017 - 06/2014
3	Glioblastoma (Glioblastoma Multiforme) 09/2016 - 05/2008
3	Thrombocytopenia (Thrombopenia) 01/2014 - 02/2006
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2021 - 11/2004
2	Ileus 01/2020 - 08/2015
2	Multiple Myeloma 10/2019 - 12/2007
2	Infections 04/2018 - 08/2010
2	Esophageal Neoplasms (Esophageal Cancer) 01/2017 - 01/2004
2	Sarcoma (Soft Tissue Sarcoma) 12/2016 - 10/2014
2	Peripheral Nervous System Diseases (PNS Diseases) 12/2016 - 10/2013
2	Proteinuria 12/2016 - 12/2003
2	Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction) 05/2016 - 04/2013
2	Hypertension (High Blood Pressure) 10/2015 - 01/2010

Drug/Important Bio-Agent (IBA)

36	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 05/2003
26	Capecitabine (Xeloda)FDA Link 10/2022 - 02/2004
25	Fluorouracil (Carac)FDA LinkGeneric 10/2022 - 11/2003
21	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 03/2004
20	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2022 - 12/2011
19	Irinotecan (Camptosar)FDA LinkGeneric 11/2021 - 06/2004
15	Dasatinib (BMS 354825)FDA Link 03/2020 - 01/2014
14	Cetuximab (Erbitux)FDA Link 06/2022 - 04/2014
13	Bevacizumab (Avastin)FDA Link 11/2021 - 01/2011
12	Leucovorin (Folinic Acid)FDA Link 10/2022 - 12/2011
11	Peptides (Polypeptides)IBA 02/2019 - 06/2007
8	TegafurIBA 02/2022 - 04/2010
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2003
8	XELOXIBA 01/2017 - 01/2011
7	UracilIBA 02/2022 - 07/2014
6	Pharmaceutical PreparationsIBA 01/2021 - 02/2006
6	Imatinib Mesylate (Gleevec)FDA Link 01/2018 - 10/2010
5	Panitumumab (Vectibix)FDA Link 12/2022 - 01/2017
5	pyrimidineIBA 01/2022 - 09/2003
5	Tyrosine Kinase InhibitorsIBA 03/2020 - 10/2017
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2019 - 02/2004
5	Protein Subunit VaccinesIBA 01/2018 - 04/2006
4	VaccinesIBA 02/2019 - 05/2008
4	S-1 plus cisplatinIBA 01/2018 - 04/2010
4	PicibanilIBA 04/2016 - 05/2001
3	Indicators and Reagents (Reagents)IBA 01/2022 - 10/2004
3	Carcinoembryonic AntigenIBA 01/2022 - 01/2003
3	gosha-jinki-ganIBA 10/2021 - 12/2009
3	Messenger RNA (mRNA)IBA 07/2020 - 06/2007
3	ErbB Receptors (EGF Receptor)IBA 11/2019 - 09/2011
3	Carboplatin (JM8)FDA LinkGeneric 11/2019 - 04/2017
3	HLA-A*24:02 antigenIBA 02/2019 - 02/2014
3	hange-shashintoIBA 01/2018 - 05/2014
3	polysaccharide-KIBA 01/2018 - 04/2006
3	Trastuzumab (Herceptin)FDA Link 01/2017 - 09/2011
3	Epidermal Growth Factor (EGF)IBA 01/2017 - 07/2014
3	Monoclonal AntibodiesIBA 01/2017 - 11/2006
3	Alanine Transaminase (SGPT)IBA 12/2016 - 11/2008
3	AntigensIBA 11/2006 - 01/2003
2	CytokinesIBA 01/2020 - 08/2010
2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2019 - 12/2015
2	Drinking WaterIBA 05/2018 - 06/2010
2	CreatinineIBA 01/2018 - 12/2003
2	Phosphotransferases (Kinase)IBA 10/2017 - 01/2014
2	taxaneIBA 01/2017 - 04/2013
2	Immunoglobulin G (IgG)IBA 09/2016 - 08/2010
2	thiamine triphosphorate (TTP)IBA 07/2016 - 08/2006
2	LentinanIBA 01/2016 - 07/2009

Therapy/Procedure

60	Drug Therapy (Chemotherapy) 06/2022 - 01/2002
59	Therapeutics 10/2022 - 09/2003
38	Adjuvant Chemotherapy 09/2022 - 01/2004
14	Gastrectomy 02/2021 - 01/2004
12	Neoadjuvant Therapy 07/2020 - 01/2003
7	Lymph Node Excision (Lymph Node Dissection) 11/2021 - 01/2004
6	Combination Drug Therapy (Combination Chemotherapy) 08/2012 - 11/2003
5	Immunotherapy 01/2018 - 12/2007
4	Drug Tapering 12/2020 - 02/2006
4	TP protocol 01/2014 - 04/2007
3	Oral Administration 05/2021 - 01/2015
3	Pancreaticoduodenectomy 01/2020 - 04/2013
3	Kampo Medicine (Kampo) 07/2015 - 04/2013